PharmaBoardroom

5 More Biotechs to Watch in China

Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making waves in the world’s…

GW Pharma’s CBD Drug Profits Soar in 2nd Quarter 2019

GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019, demonstrating that cannabinoid-based…

Uli Hacksell – CEO & President, Medivir, Sweden

Medivir is a Swedish biotech company focusing on the development and commercialization of innovative treatments for cancers of high unmet medical…

Somvong Tragoonrung – Executive Director, BIOTEC, Thailand

Dr Somvong Tragoonrung, executive director of BIOTEC, one of the first biotechnology-focused research institutes in Thailand, highlights their current…

Kai Lamottke – Co-Founder, Managing Director (Germany)…

Dr Kai Lamottke, co-founder and MD of Bicoll GmbH, Munich, and since 2001, GM and board member of Bicoll Biotechnology (Shanghai) Co. Ltd discusses…

Shing-Mou Lee – Founder and President, EMO Biomedicine,…

Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory…

Germany: The Essential Requirements on Trading Medical Cannabis…

Dentons Germany's Peter Homberg outlines the key requirements that companies need to fulfil in order to import medical cannabis into Germany and how…

Taiwan Biotech Snapshot

Taiwan's biotechnology industry was valued at USD 3.3 billion in 2016, representing around 26 percent of the island's total biopharmaceutical market,…

HB Chen – President, TaiwanBio Therapeutics

HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique…

5 People You Should Know in Taiwanese Life Sciences

Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and…

Bayer: Betting Big on Cell & Gene Therapy

Bayer's latest move to buy out BlueRock Therapeutics comes with a price tag of USD 600 million in total as the company increasingly looks toward cell…

Zheru Zhang – President; Jielun Zhu – CFO, I-Mab…

Zheru Zhang and Jielun Zhu of I-Mab Biopharma, shares their vision for the ambitious biotech company looking to develop their dual-pronged strategy of…

Tagged with BI